Department of Biochemistry, Albert Einstein College of Medicine, Michael F. Price Center for Translational Research, 1301 Morris Park Avenue, Bronx, New York 10461, United States.
Chem Rev. 2020 Mar 25;120(6):3210-3229. doi: 10.1021/acs.chemrev.9b00472. Epub 2019 Dec 5.
Vaccines have had a profound impact on the management and prevention of infectious disease. In addition, the development of vaccines against chronic diseases has attracted considerable interest as an approach to prevent, rather than treat, conditions such as cancer, Alzheimer's disease, and others. Subunit vaccines consist of nongenetic components of the infectious agent or disease-related epitope. In this Review, we discuss peptide-based vaccines and their potential in three therapeutic areas: infectious disease, Alzheimer's disease, and cancer. We discuss factors that contribute to vaccine efficacy and how these parameters may potentially be modulated by design. We examine both clinically tested vaccines as well as nascent approaches and explore current challenges and potential remedies. While peptide vaccines hold substantial promise in the prevention of human disease, many obstacles remain that have hampered their clinical use; thus, continued research efforts to address these challenges are warranted.
疫苗对传染病的管理和预防产生了深远的影响。此外,针对慢性疾病的疫苗的开发作为一种预防而非治疗癌症、阿尔茨海默病等疾病的方法引起了相当大的关注。亚单位疫苗由传染性病原体或与疾病相关的表位的非遗传成分组成。在这篇综述中,我们讨论了基于肽的疫苗及其在三个治疗领域的潜力:传染病、阿尔茨海默病和癌症。我们讨论了有助于疫苗效力的因素,以及这些参数如何通过设计来潜在地调节。我们既研究了临床测试的疫苗,也研究了新生方法,并探讨了当前的挑战和潜在的补救措施。虽然肽疫苗在预防人类疾病方面具有很大的潜力,但仍存在许多阻碍其临床应用的障碍;因此,有必要继续努力研究这些挑战。